2,000 Shares in UiPath Inc. (NYSE:PATH) Acquired by Tennessee Valley Asset Management Partners

Tennessee Valley Asset Management Partners purchased a new position in shares of UiPath Inc. (NYSE:PATHFree Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 2,000 shares of the healthcare company’s stock, valued at approximately $50,000.

A number of other large investors have also bought and sold shares of PATH. HighMark Wealth Management LLC acquired a new position in UiPath during the 4th quarter worth $27,000. Fifth Third Bancorp lifted its holdings in UiPath by 2,005.3% during the 3rd quarter. Fifth Third Bancorp now owns 2,000 shares of the healthcare company’s stock worth $34,000 after buying an additional 1,905 shares in the last quarter. FNY Investment Advisers LLC acquired a new position in UiPath during the 4th quarter worth $40,000. FSC Wealth Advisors LLC acquired a new position in UiPath during the 4th quarter worth $43,000. Finally, Allspring Global Investments Holdings LLC lifted its holdings in UiPath by 792.7% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 2,089 shares of the healthcare company’s stock worth $52,000 after buying an additional 1,855 shares in the last quarter. 62.50% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research analysts have issued reports on PATH shares. Truist Financial reaffirmed a “buy” rating and set a $32.00 price objective on shares of UiPath in a report on Wednesday, March 20th. TD Cowen increased their price target on UiPath from $25.00 to $28.00 and gave the company an “outperform” rating in a research note on Thursday, March 14th. Canaccord Genuity Group increased their price target on UiPath from $27.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, March 15th. BMO Capital Markets increased their price target on UiPath from $24.00 to $28.00 and gave the company a “market perform” rating in a research note on Thursday, March 14th. Finally, Morgan Stanley increased their price target on UiPath from $17.00 to $25.00 and gave the company an “equal weight” rating in a research note on Thursday, March 14th. Nine analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $27.41.

Check Out Our Latest Analysis on UiPath

UiPath Trading Up 3.4 %

PATH stock opened at $19.54 on Wednesday. The stock has a 50-day moving average price of $22.55 and a two-hundred day moving average price of $21.56. The stock has a market cap of $11.12 billion, a PE ratio of -114.94 and a beta of 0.96. UiPath Inc. has a 1 year low of $12.38 and a 1 year high of $27.87.

UiPath (NYSE:PATHGet Free Report) last released its earnings results on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.10. The firm had revenue of $405.25 million during the quarter, compared to analysts’ expectations of $383.32 million. UiPath had a negative return on equity of 3.29% and a negative net margin of 6.87%. On average, analysts forecast that UiPath Inc. will post -0.04 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, CFO Ashim Gupta sold 16,000 shares of the firm’s stock in a transaction dated Friday, March 15th. The stock was sold at an average price of $22.84, for a total value of $365,440.00. Following the completion of the transaction, the chief financial officer now owns 87,505 shares in the company, valued at approximately $1,998,614.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In the last 90 days, insiders sold 72,000 shares of company stock worth $1,591,360. Corporate insiders own 31.03% of the company’s stock.

UiPath Profile

(Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Further Reading

Institutional Ownership by Quarter for UiPath (NYSE:PATH)

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.